The store will not work correctly when cookies are disabled.
3-Phenyl-5-(3-hydroxyphenyl)-1H-pyrrolo[2,3-b]pyridine
ID: ALA3102937
PubChem CID: 59699868
Max Phase: Preclinical
Molecular Formula: C19H14N2O
Molecular Weight: 286.33
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Oc1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1
Standard InChI: InChI=1S/C19H14N2O/c22-16-8-4-7-14(9-16)15-10-17-18(12-21-19(17)20-11-15)13-5-2-1-3-6-13/h1-12,22H,(H,20,21)
Standard InChI Key: ITYVMPQOIASLBW-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 25 0 0 0 0 0 0 0 0999 V2000
33.0329 -8.9862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0317 -9.8131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7461 -10.2257 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.7443 -8.5737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3188 -8.5741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4592 -8.9826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4595 -9.8131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2494 -10.0696 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.7376 -9.3975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2490 -8.7258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6368 -7.9989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4615 -7.9740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8495 -7.2474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4136 -6.5466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5853 -6.5770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2010 -7.3041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3220 -7.7487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6087 -7.3367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8937 -7.7491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8966 -8.5780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6105 -8.9862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1841 -8.9929 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 7 2 0
6 4 2 0
4 1 1 0
1 5 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 6 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
5 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 5 1 0
20 22 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 286.33 | Molecular Weight (Monoisotopic): 286.1106 | AlogP: 4.60 | #Rotatable Bonds: 2 |
Polar Surface Area: 48.91 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.80 | CX Basic pKa: 2.95 | CX LogP: 4.21 | CX LogD: 4.21 |
Aromatic Rings: 4 | Heavy Atoms: 22 | QED Weighted: 0.57 | Np Likeness Score: -0.12 |
References
1. Gourdain S, Dairou J, Denhez C, Bui LC, Rodrigues-Lima F, Janel N, Delabar JM, Cariou K, Dodd RH.. (2013) Development of DANDYs, new 3,5-diaryl-7-azaindoles demonstrating potent DYRK1A kinase inhibitory activity., 56 (23): [PMID:24188002] [10.1021/jm401049v] |